Search Results - "KOIZUMI, W"

Phase I study of TAS-102 treatment in Japanese patients with advanced solid tumours by Doi, T, Ohtsu, A, Yoshino, T, Boku, N, Onozawa, Y, Fukutomi, A, Hironaka, S, Koizumi, W, Sasaki, T

“…Background: TAS-102 consists of α, α, α-trifluorothymidine (TFT) and an inhibitor of thymidine phosphorylase (TPI). We conducted a dose-escalation phase I…”
Get full text

Phase II study of oxaliplatin plus S-1 as first-line treatment for advanced gastric cancer (G-SOX study) by Koizumi, W., Takiuchi, H., Yamada, Y., Boku, N., Fuse, N., Muro, K., Komatsu, Y., Tsuburaya, A.

“…Background: The efficacy and safety of oxaliplatin combined with S-1 (SOX regimen) for unresectable advanced or recurrent gastric cancer were investigated…”
Get full text

P-135The role of Angiotensin II subtype IA receptor on liver metastasis formation by Shimizu, Y, Amano, H, Koizumi, W, Majima, M

Get full text

Phase I II study of S-1 combined with cisplatin in patients with advanced gastric cancer by Koizumi, W, Tanabe, S, Saigenji, K, Ohtsu, A, Boku, N, Nagashima, F, Shirao, K, Matsumura, Y, Gotoh, M

“…A dose-escalation study of cisplatin (CDDP) combined with S-1, a new oral dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine, was performed to…”
Get full text

Relation of overall survival, progression free survival, post progression survival and response rate in four randomized Japanese phase III trials comparing various combinations of S-1 therapy for first-line treatment of advanced gastric cancer by Takeuchi, M., Ichikawa, W., Shitara, K., Sunakawa, Y., Oba, K., Koizumi, W., Sakata, Y., Furukawa, H., Takeuchi, M., Fujii, M.

Get full text

A phase I study of IRISOX (irinotecan/S-1/oxaliplatin) in the second-line treatment for gemcitabine-refractory pancreatic cancer by Miyata, E., Okuwaki, K., Imaizumi, H., Kida, M., Iwai, T., Yamauchi, H., Kaneko, T., Hasegawa, R., Adachi, K., Tadehara, M., Koizumi, W.

Get full text

Meta-analysis of biweekly irinotecan plus cisplatin versus irinotecan alone as second-line treatment for advanced gastric cancer by Nishikawa, K., Koizumi, W., Tsuburaya, A., Yamanaka, T., Morita, S., Fujitani, K., Akamaru, Y., Shimada, K., Hosaka, H., Nakayama, N., Miyashita, Y., Tsujinaka, T., Sakamoto, J.

Get full text

Analysis of BRCAness with MLPA in pancreatic ductal adenocarcinoma patients using FFPE sample obtained via EUS-FNAB by Okuwaki, K., Imaizumi, H., Masutani, H., Yoshida, T., Kida, M., Iwai, T., Yamauchi, H., Kaneko, T., Hasegawa, R., Miyata, E., Adachi, K., Tadehara, M., Koizumi, W.

Get full text

P974 EARLY EVALUATION OF RESPONSE TO SORAFENIB FOR HEPATOCELLULAR CARCINOMA BY DUPLEX DOPPLER ULTRASONOGRAPHY by Hidaka, H, Nakazawa, T, Koizumi, W

Get full text

Association of variants in genes encoding for macrophage-related functions with clinical outcome in patients with locoregional gastric cancer by Sunakawa, Y., Stremitzer, S., Cao, S., Zhang, W., Yang, D., Wakatsuki, T., Ning, Y., Yamauchi, S., Stintzing, S., Sebio, A., El-khoueiry, R., Matsusaka, S., Parekh, A., Barzi, A., Azuma, M., Watanabe, M., Koizumi, W., Lenz, H.-J.

“…We provide the first evidence demonstrating that single-nucleotide polymorphisms in macrophage function-related genes may predict prognosis in locoregional…”
Get full text

Propofol sedation with bispectral index monitoring is useful for endoscopic submucosal dissection: a randomized prospective phase II clinical trial by Sasaki, T, Tanabe, S, Azuma, M, Sato, A, Naruke, A, Ishido, K, Katada, C, Higuchi, K, Koizumi, W

“…Endoscopic submucosal dissection (ESD) has become a standard treatment. However, the treatment time tends to be relatively long and insufflation and…”
Get more information

Narrow band imaging for detecting superficial squamous cell carcinoma of the head and neck in patients with esophageal squamous cell carcinoma by Katada, C, Tanabe, S, Koizumi, W, Higuchi, K, Sasaki, T, Azuma, M, Katada, N, Masaki, T, Nakayama, M, Okamoto, M, Muto, M

“…Narrow band imaging combined with magnifying endoscopy (NBI-ME) is useful for the detection of superficial squamous cell carcinoma (SCC) within the oropharynx,…”
Get more information

Endoscopic management of malignant biliary obstruction by means of covered metallic stents: primary stent placement vs. re-intervention by Kida, M, Miyazawa, S, Iwai, T, Ikeda, H, Takezawa, M, Kikuchi, H, Watanabe, M, Imaizumi, H, Koizumi, W

“…Recent progress in chemotherapy has prolonged the survival of patients with malignant biliary strictures, leading to increased rates of stent occlusion…”
Get more information

Randomised phase II study of S-1/cisplatin plus TSU-68 vs S-1/cisplatin in patients with advanced gastric cancer by Koizumi, W, Yamaguchi, K, Hosaka, H, Takinishi, Y, Nakayama, N, Hara, T, Muro, K, Baba, H, Sasaki, Y, Nishina, T, Fuse, N, Esaki, T, Takagi, M, Gotoh, M, Sasaki, T

“…Background: This study aimed to determine whether combination S-1 plus cisplatin (CDDP) therapy, the most widely used therapy for Japanese patients with…”
Get full text

Genetic variations in immunomodulatory pathways to predict survival in patients with locoregional gastric cancer by Sunakawa, Y, Cao, S, Volz, N B, Berger, M D, Yang, D, Parekh, A, Zhang, W, Matsusaka, S, Ning, Y, Stremitzer, S, Stintzing, S, Sebio, A, Okazaki, S, Wakatsuki, T, Azuma, M, Watanabe, M, Koizumi, W, Wu, A H, Lenz, H-J

“…Immunomodulator-targeting therapies are under development in gastric cancer (GC). However, the role of genes modulating anti-tumor immunity in GC remains…”
Get full text

Expansion of the indications for endoscopic mucosal resection in patients with superficial esophageal carcinoma by Higuchi, K, Tanabe, S, Koizumi, W, Sasaki, T, Nakatani, K, Saigenji, K, Kobayashi, N, Mitomi, H

“…Endoscopic mucosal resection (EMR) is a minimally invasive local treatment for superficial esophageal carcinoma (SEC). The use of EMR in patients with m3 or…”
Get more information

Fine needle aspiration using forward-viewing endoscopic ultrasonography by Kida, M, Araki, M, Miyazawa, S, Ikeda, H, Kikuchi, H, Watanabe, M, Imaizumi, H, Koizumi, W

“…A prototype forward-viewing instrument has been developed for therapeutic endoscopic ultrasound (EUS)-guided fine needle aspiration (FNA). We had the…”
Get more information

Estrogen receptor-beta genetic variations and overall survival in patients with locally advanced gastric cancer by Sunakawa, Y, Cao, S, Berger, M D, Matsusaka, S, Yang, D, Zhang, W, Ning, Y, Parekh, A, Stremitzer, S, Mendez, A, Okazaki, S, Wakatsuki, T, Azuma, M, Shimada, K, Watanabe, M, Koizumi, W, Wu, A H, Lenz, H-J

“…Estrogen has been shown not only to reduce the incidence of colorectal cancer but also gastric cancer (GC). Polymorphisms in estrogen receptor β gene, ESR2 ,…”
Get full text

Factors associated with the presence of multiple Lugol-voiding lesions in patients with esophageal squamous-cell carcinoma by Katada, C., Muto, M., Tanabe, S., Higuchi, K., Sasaki, T., Azuma, M., Ishido, K., Katada, N., Sakuramoto, S., Yamashita, K., Masaki, T., Nakayama, M., Okamoto, M., Koizumi, W.

“…Summary Multicentric squamous dysplasia of the esophagus is characterized by multiple Lugol‐voiding lesions (LVLs) on Lugol chromoendoscopy. Multiple LVLs are…”
Get full text

Randomised phase II study of S-1/cisplatin plus TSU-68 vs S-1/cisplatin in patients with advanced gastric cancer by Koizumi, W, Yamaguchi, K, Hosaka, H, Takinishi, Y, Nakayama, N, Hara, T, Muro, K, Baba, H, Sasaki, Y, Nishina, T, Fuse, N, Esaki, T, Takagi, M, Gotoh, M, Sasaki, T

Get full text